Literature DB >> 4726072

Comparison of indomethacin and phenylbutazone in acute gout.

C J Smyth, J S Percy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4726072      PMCID： PMC1006115          DOI： 10.1136/ard.32.4.351

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  14 in total

1.  INDOMETHACIN: A NEW NON-STEROID ANTI-INFLAMMATORY AGENT.

Authors:  F D HART; P L BOARDMAN
Journal:  Br Med J       Date:  1963-10-19

2.  Gout.

Authors:  R H FREYBERG
Journal:  Arthritis Rheum       Date:  1962-12

3.  [Antibody-conditioned thrombocytopenic purpura caused by phenylbutazone].

Authors:  H G MEIERS; G GEHRMANN; W GAHLEN
Journal:  Dtsch Med Wochenschr       Date:  1963-03-22       Impact factor: 0.628

4.  Enzymatic determination of uric acid; with detailed directions.

Authors:  E PRAETORIUS; H POULSEN
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

Review 5.  Indomethacin--its rightful place in treatment.

Authors:  C J Smyth
Journal:  Ann Intern Med       Date:  1970-03       Impact factor: 25.391

6.  Regimen of indomethacin therapy in acute gouty arthritis.

Authors:  B T Emmerson
Journal:  Br Med J       Date:  1967-04-29

7.  Gout and gouty arthritis. Current concepts and management.

Authors:  E W Boland
Journal:  Calif Med       Date:  1966-10

8.  Current trends in therapy of rheumatoid conditions.

Authors:  L Berman
Journal:  S Afr Med J       Date:  1965-10-30

9.  [Acute thrombocytopenic purpura after phenylbutazone therapy].

Authors:  K Dvorák; E Blazková
Journal:  Vnitr Lek       Date:  1965-10

10.  Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone.

Authors:  B B BRODIE; E W LOWMAN; J J BURNS; P R LEE; T CHENKIN; A GOLDMAN; M WEINER; J M STEELE
Journal:  Am J Med       Date:  1954-02       Impact factor: 4.965
View more
  14 in total

1.  Inflammatory disease and its control in rheumatic disorders.

Authors:  F D Hart
Journal:  Br Med J       Date:  1975-10-25

Review 2.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

Review 3.  The challenges of gout management in the elderly.

Authors:  Lisa K Stamp; Sarah Jordan
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

4.  Matching the Drug to the Patient: The rational use of antiarthritic drugs.

Authors:  P Lee
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

5.  Letter: Treatment of acute gout.

Authors:  I Haslock
Journal:  Br Med J       Date:  1974-04-13

Review 6.  The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia.

Authors:  B Dubinsky; S Gebre-Mariam; R J Capetola; M E Rosenthale
Journal:  Agents Actions       Date:  1987-02

Review 7.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 8.  Management of acute and chronic gouty arthritis: present state-of-the-art.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.

Authors:  R C Butler; D H Goddard; C S Higgens; P Hollingworth; C T Pease; M A Stodell; J T Scott
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

Review 10.  Overview of the management of acute gout and the role of adrenocorticotropic hormone.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2008       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.